Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,852 papers from all fields of science
Search
Sign In
Create Free Account
NZ 419
Known as:
NZ-419
, NZ419 cpd
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
5-hydroxy-1-methylhydantoin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The Radical Scavenger NZ-419 Suppresses Intestinal Polyp Development in Apc-Mutant Mice
Y. Kurokawa
,
Gen Fujii
,
+8 authors
M. Mutoh
Journal of Clinical Medicine
2020
Corpus ID: 210863786
Colorectal cancer is the fourth leading cause of cancer death worldwide, and it is important to establish effective methods for…
Expand
2014
2014
Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells
K. Ienaga
,
M. Sohn
,
M. Naiki
,
A. Jaffa
Journal of Receptor and Signal Transduction…
2014
Corpus ID: 36572755
Abstract A creatinine metabolite, 5-hydroxy-1-methylhydantoin (HMH: NZ-419), a hydroxyl radical scavenger, has previously been…
Expand
2013
2013
Protective effect of an intrinsic antioxidant, HMH (5-hydroxy-1-methylhydantoin; NZ-419), against cellular damage of kidney tubules.
K. Ienaga
,
C. Park
,
T. Yokozawa
Experimental and Toxicological Pathology
2013
Corpus ID: 41579523
2011
2011
Creatinine and HMH (5-hydroxy-1-methylhydantoin, NZ-419) as intrinsic hydroxyl radical scavengers.
K. Ienaga
,
T. Yokozawa
Drug Discoveries & Therapeutics
2011
Corpus ID: 14004586
Creatinine (Crn) is one of the main intrinsic hydroxyl radical (•OH) scavengers and an ideal one for healthy or normal mammals…
Expand
2011
2011
Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1- methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease.
G. Hasegawa
,
K. Nakano
,
K. Ienaga
Clinical Nephrology
2011
Corpus ID: 25570675
AIMS In mammals, creatinine (Cr) is catabolized by a dual oxidative pathway via 5-hydroxy-1-methylhydantoin or 5…
Expand
2010
2010
Treatment with NZ-419 (5-Hydroxy-1-methylimidazoline-2,4-dione), a novel intrinsic antioxidant, against the progression of chronic kidney disease at stages 3 and 4 in rats.
K. Ienaga
,
T. Yokozawa
Biological and Pharmaceutical Bulletin
2010
Corpus ID: 13407045
For rats, glomerular filtration rate (GFR) and its relative GFR (ratio to normal GFR(0)) were estimated in order to classify…
Expand
2009
2009
First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats.
K. Ienaga
,
Hiroki Mikami
,
T. Yokozawa
Biological and Pharmaceutical Bulletin
2009
Corpus ID: 5224220
The concentration of NZ-419 (5-hydroxy-1-methylimidazolidine-2,4-dione), an intrinsic antioxidant, has been shown to increase in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE